The inhibition of human factor VIIa-tissue factor by antithrombin III-heparin is enhanced by factor X on a human bladder carcinoma cell line

International Journal of Hematology

Volumn 63, Issue 1, 1996, Pages 51-63

  Hamamoto, Takayoshi ^a,c   Foster, Donald C ^b   Kisiel, Walter ^a  

^a UNIVERSITY OF NEW MEXICO SCHOOL OF MEDICINE   (United States)

^b ZYMOGENETICS INC   (United States)

^c Kaketsuken   (Japan)

Author keywords

Antithrombin III; Factor VIIa; Factor X; Heparin; Tissue factor

Indexed keywords

ANTITHROMBIN III; BLOOD CLOTTING FACTOR 10; BLOOD CLOTTING FACTOR 7A; HEPARIN; THROMBOPLASTIN;

ARTICLE; BLADDER CARCINOMA; BLOOD CLOTTING; CONTROLLED STUDY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR CELL LINE;

ANTITHROMBIN III; DRUG SYNERGISM; FACTOR VIIA; FACTOR X; HEPARIN; HUMANS; THROMBOPLASTIN; TUMOR CELLS, CULTURED; URINARY BLADDER NEOPLASMS;

EID: 0030049736     PISSN: 09255710     EISSN: None     Source Type: Journal    
DOI: 10.1016/0925-5710(95)00422-x     Document Type: Article

References (33)

1. Davie EW, Fujikawa K, Kisiel W. The coagulation cascade: initiation, maintenance, and regulation. Biochemistry 1991;30:10363-10370.
2. Rapaport SI. Inhibition of factor VIIa/tissue factor-induced blood coagulation: with particular emphasis upon a factor Xa-dependent inhibitory mechanism. Blood 1989;73:359-365.
3. Broze GJ Jr. The role of tissue factor pathway inhibitor in a revised coagulation cascade. Semin Hematol 1992;29:159-169.
4. Broze GJ Jr, Warren LA, Novotny WF, Higuchi DA, Girard JJ, Miletich JP. The lipoprotein-associated coagulation inhibitor that inhibits the factor VII tissue factor complex also inhibits factor Xa: insight into its possible mechanism of action. Blood 1988;71:335-343.
5. Warn-Cramer BJ, Rao LV, Maki SL, Rapaport SI. Modifications of extrinsic pathway inhibitor (EPI) and factor Xa that affect their ability to interact and to inhibit factor VIIa/tissue factor: evidence for a two-step model of inhibition. Thromb Haemost 1988;60:453-456.
6. Girard TJ, Warren LA, Novotny WF, Likert KM, Brown SG, Miletich JP, Broze GJ Jr. Functional significance of the Kunitz-type inhibitory domains of lipoprotein associated coagulation inhibitor. Nature 1989; 338:518-520.
7. Lawson JH, Butenas S, Ribarik N, Mann KG. Complex-dependent inhibition of factor VIIa by antithrombin III and heparin. J Biol Chem 1993;268:767-770.
8. Rao LV, Rapaport SI, Hoang AD. Binding of factor VIla to tissue factor permits rapid antithrombin III/heparin inhibition of factor VIIa. Blood 1993;81:2600-2607.
9. Hamamoto T, Yamamoto M, Nordfang O, Petersen JG, Foster DC, Kisiel W. Inhibitory properties of full-length and truncated recombinant tissue factor pathway inhibitor (TFPI). Evidence that the third Kunitz-type domain of TFPI is not essential for the inhibition of factor VIIa-tissue factor complexes on cell surfaces. J Biol Chem 1993;268:8704-8710.
10. Rao LV, Nordfang O, Hoang AD, Pendurthi UR. Mechanism of antithrombin III inhibition of factor VIIa/tissue factor activity on cell surfaces. Comparison with tissue factor pathway inhibitor/factor Xa-induced inhibition of factor VIIa/tissue factor activity. Blood 1995;85:121-129.
11. Kondo S, Kisiel W. Evidence that plasma lipoproteins in-hibit the factor VIIa-tissue factor complex by a different mechanism than extrinsic pathway inhibitor. Blood 1987;70:1947-1954.
12. Dahlback B. Purification of human vitamin K-dependent protein S and its limited proteolysis by thrombin. Biochem J 1983;209:837-846.
13. Stern DM, Nawroth PP, Kisiel W, Handley D, Drillings M, Bartos J. A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin. J Clin Invest 1984;74:1910-1921.
14. Nordfang O, Bjorn SE, Valentin S, Nielsen LS, Wildgoose P, Beck TC, Hedner U. The C-terminus of tissue factor pathway inhibitor is essential to its anticoagulant activity. Biochemistry 1991;30:10371-10376.
15. Thim L, Bjoern S, Christensen M, Nicolaisen EM, Lund-Hansen T, Pedersen AH, Hedner U. Amino acid sequence and posttranslational modifications of human factor VIla from plasma and transfected baby hamster kidney cells. Biochemistry 1988;27:7785-7793.
16. Kazama Y, Komiyama Y, Kisiel W. Tissue factor pathway inhibitor and protease nexin-1 are major factor Xa binding proteins on the HepG2 cell surface. Blood 1993;81:676-682.
17. Morita T, Jackson CM. Preparation and properties of derivatives of bovine factor X and factor Xa from which the gamma-carboxyglutamic acid containing domain has been removed. J Biol Chem 1986;261:4015-4023.
18. Wildgoose P, Kisiel W. Inhibition of prothrombin activation by factor X and factor IX Gla-peptides. Biochem Biophys Res Commun 1988;152:1207-1212.
19. Mahoney WC, Kurachi K, Hermodson MA. Formation and dissociation of the covalent complexes between trypsin and two homologous inhibitors, alpha 1-antitrypsin and antithrombin III. Eur J Biochem 1980;105:545-552.
20. Ruf W, Rehemtulla A, Morrissey JH, Edgington TS. Phospholipid-independent and -dependent interactions required for tissue factor receptor and cofactor function. J Biol Chem 1991;266:2158-2166.
21. Paborsky LR, Tate KM, Harris RJ et al. Purification of recombinant human tissue factor. Biochemistry 1989;28: 8072-8077.
22. Paborsky LR, Caras IW, Fisher KL, Gorman CM. Lipid association, but not the transmembrane domain, is required for tissue factor activity. Substitution of the transmembrane domain with a phosphatidylinositol anchor. J Biol Chem 1991;266:21 911-21 916.
23. Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970;227:680-685.
24. Engvall E. Enzyme immunoassay ELISA and EMIT. Methods Enzymol 1980;70:419-439.
25. Wildgoose P, Berkner KL, Kisiel W. Synthesis, purification, and characterization of an Arg152→Glu site directed mutant of recombinant human blood clotting factor VII. Biochemistry 1990;29:3413-3420.
26. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
27. Broze GJ Jr, Leykam JE, Schwartz BD, Miletich JP. Purification of human brain tissue factor. J Biol Chem 1985;260:10 917-10 920.
28. Bach R, Gentry R, Nemerson Y. Factor VII binding to tissue factor in reconstituted phospholipid vesicles: induction of cooperativity by phosphatidylserine. Biochemistry 1986;25:4007-4020.
29. Barenholz Y, Gibbes D, Litman BJ, Goll J, Thompson TE, Carlson RD. A simple method for the preparation of homogeneous phospholipid vesicles. Biochemistry 1977;16:2806-2810.
30. Sakai T, Lund-Hansen T, Paborsky L, Pedersen AH, Kisiel W. Binding of human factors VII and VIla to a human bladder carcinoma cell line (J82). Implications for the initiation of the extrinsic pathway of blood coagulation. J Biol Chem 1989;264:9980-9988.
31. Krishnaswamy S, Field KA, Edgington TS, Morrissey JH, Mann KG. Role of the membrane surface in the activation of human coagulation factor X. J Biol Chem 1992;267:26 110-26 120.
32. Nelsestuen GL, Kisiel W, Di Scipio RG. Interaction of vitamin K dependent proteins with membranes. Biochemistry 1978;17:2134-2138.
33. Bajaj SP, Rapaport SI, Prodanos C. A simplified procedure for purification of human prothrombin, factor IX and factor X. Prep Biochem 1981;11:397-412.